Management of Refractory, Moderate to Severe Atopic Dermatitis: The Expanding Role of Oral JAK Inhibitors

Clinical Advisor·Oct 23

This story is reported by Clinical Advisor. Read what other outlets are saying below, then open the original report for full details.